This review concluded that the Edinburgh Postnatal Depression Scale was a precise and validated test for identifying post-natal depression. There was insufficient evidence that use of identification strategies improved clinical outcomes. The conclusions on diagnostic accuracy appear reliable. The lower methodological quality and more limited evidence of the effectiveness review suggest that its conclusions should be treated with some caution.
Study selection
Diagnostic accuracy: Studies of women in the prenatal or post-natal (up to one year) period that compared an identification test for depression with a reference standard (diagnostic interview) were eligible for inclusion. Studies could be cross-sectional, case-control, cohort or randomised controlled trials (RCTs) . Most studies evaluated the Edinburgh Postnatal Depression Scale (EPDS) alone or in combination with other strategies. Studies were conducted in a variety of populations and settings, with EPDS cut-off points for depression ranging from 7 to 16. Outcomes were assessed at different time points across studies.
Clinical effectiveness: RCTs or controlled trials in any setting that compared the implementation of an identification strategy, with or without additional enhancement of care, with standard primary care were eligible for inclusion. Studies had to report maternal and/or infant outcomes. Included trials compared use of an identification strategy (followed by treatment of those identified) with usual care or used an identification strategy in all women and evaluated the effect of feeding back the results. These trials were designated level I or II evidence. Trials that used the identification strategy solely to assess eligibility (i.e. to exclude women without post-natal depression) were also eligible (level III evidence) and formed the majority of included studies.
Two reviewers independently selected studies for inclusion; disagreements were resolved by consensus, with reference to a third reviewer if necessary.
Assessment of study quality
Validity of diagnostic accuracy studies was assessed by two independent reviewers using the QUADAS (positive predictive value) checklist.
The authors did not state that they assessed validity of clinical effectiveness studies.
Data extraction
Diagnostic accuracy: Sensitivity, specificity, positive and negative likelihood ratios and diagnostic odds ratios were extracted or calculated. Data were extracted from English language articles by two independent reviewers. Articles in other languages were extracted by one reviewer with the help of a translator.
Clinical effectiveness: For dichotomous outcomes, numbers of participants and outcomes in each group were extracted to calculate an odds ratio (OR) and associated 95% confidence interval (CI) . For continuous outcomes, group means and standard deviations were extracted when reported to calculate a mean difference and associated 95% confidence interval. Data were extracted by one reviewer.
Methods of synthesis
Diagnostic accuracy: Studies that used the same identification strategy and cut point were pooled using a bivariate analysis. Pooled estimates of sensitivity, specificity, positive and negative likelihood ratios and diagnostic odds ratios and associated 95% confidence intervals were calculated. Between-study heterogeneity was assessed using the I 2 statistic of the pooled diagnostic odds ratio. To explore heterogeneity, summary receiver-operating characteristic (ROC) curves were constructed and used to identify studies that lay outside a 95% confidence ellipse in ROC space. A weighted multivariate meta-regression analysis was used to evaluate the influence of time since birth, baseline prevalence of depression and study quality features as sources of heterogeneity.
Clinical effectiveness: Pooled odds ratios for level I or II trials were calculated using a fixed-effect model (Mantel-Haenszel method). Statistical heterogeneity was assessed using the I 2 statistic. Continuous outcomes were not pooled because of reporting limitations. Trials providing level III evidence were synthesised in a narrative by type of study (prevention or treatment) and identification strategy used.
No evidence was found for the diagnostic accuracy or clinical effectiveness of strategies involving case finding questions.
Results of the review
Diagnostic accuracy: Sixty studies (64 publications) were included, of which 52 evaluated the Edinburgh Postnatal Depression Scale (EPDS). For the EPDS administered postnatally (47 studies), pooled estimates of sensitivity for major depression (18 studies) ranged from 0.60 (specificity 0.97) to 0.96 (specificity 0.45) depending on the cut point used. I 2 ranged from 0 to 93%. Quality varied between studies and some items were poorly reported. Generic identification strategies (Beck Depression Inventory and Hamilton Rating Scale for Depression) appeared to be less sensitive, but more specific, than the EPDS. Meta-regression analysis identified timing of administration of the EPDS (before or after six weeks postnatally) as a significant factor in explaining heterogeneity. Other analyses were reported.
Clinical effectiveness: Thirty studies (32 publications) were included. Five studies provided level I or II evidence. All the level I or II studies used the EPDS to identify post-natal depression. Pooled estimates (based on four trials) indicated that use of the EPDS significantly reduced the odds of subsequent post-natal depression, i.e. scoring above a defined threshold on the EPDS (OR 0.64, 95% CI 0.52 to 0.78). Heterogeneity was not significant (I 2 =0%). Three of the studies involved some form of enhanced care, making it difficult to isolate the effect of the identification strategy. Results for trials providing level III evidence were reported.
